Celera:Carriers of a Gene Variant are at Elevated risk of Coronary Heart Disease Which is Virtually Eliminated by Statin Therapy
New studies in more than 30,000 individuals indicate that carriers of the KIF6 gene variant have up to a 55% increased risk of a coronary event
24-Jan-2008 -
Celera, an Applera Corporation business, announced three publications reporting that a variant of the gene encoding kinesin-like protein 6 (KIF6) is associated with up to a 55% increased risk of primary and recurrent coronary heart disease (CHD) events. These research studies included a total of ...
Acute Coronary Syndrome
cardiology
cardiovascular diseases
+6